FDA Inspection 1261187 — Lingraphicare America, Inc.

Lingraphicare America, Inc. — FEI 1000123978

The FDA completed an inspection of Lingraphicare America, Inc. on Feb 3, 2025 in Princeton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 3, 2025
Fiscal Year
2025
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Princeton, NJ (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
260421 CFR 820.30(e)Design review - Lack of or inadequate procedures
310121 CFR 820.30(g)Design validation- Lack of or inadequate procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
319921 CFR 820.40(a)Document review, approval documentation
63321 CFR 803.17(a)(3)Lack of System for Timely Submission of Reports

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.